Priority Setting for Improvement of Cervical Cancer Prevention in Iran

Publish Year: 1395
نوع سند: مقاله ژورنالی
زبان: English
View: 41

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_HPM-5-4_002

تاریخ نمایه سازی: 16 مرداد 1403

Abstract:

Background Cervical cancer is the fourth most common cancer among women worldwide. Organized cervical screening and vaccination against human papilloma virus (HPV) have been successful interventions for prevention of invasive cervical cancer (ICC). Because of cultural and religious considerations, ICC has low incidence in Iran and many other Muslim countries. There is no organized cervical screening in these countries. Therefore, ICC is usually diagnosed in advanced stages with poor prognosis in these countries. We performed a priority setting exercise and suggested priorities for prevention of ICC in this setting.   Methods We invited experts and researchers to a workshop and asked them to list important suggestions for ICC prevention in Iran. After merging similar items and removing the duplicates, we asked the experts to rank the list of suggested items. We used a strategy grid and Go-zone analysis to determine final list of priorities for ICC prevention in Iran.   Results From ۲۶ final items suggested as priorities for prevention of ICC, the most important priorities were developing national guidelines for cervical screening and quality control protocol for patient follow-up and management of precancerous lesions. In addition, we emphasized considering insurance coverage for cervical screening, public awareness, and research priorities, and establishment of a cervical screening registry.   Conclusion A comprehensive approach and implementation of organized cervical screening program is necessary for prevention of ICC in Iran and other low incidence Muslim countries. Because of high cost for vaccination and low incidence of cervical cancer, we do not recommend HPV vaccination for the time being in Iran.

Keywords:

Invasive Cervical Cancer (ICC) , Priority Setting , Screening , Prevention and Control , Iran

Authors

Azam Majidi

Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

Reza Ghiasvand

Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

Maryam Hadji

Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

Azin Nahvijou

Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

Azam-Sadat Mousavi

Department of Genecology Oncology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Minoo Pakgohar

Department of Reproductive Health, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran

Nahid Khodakarami

Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mehrandokht Abedini

Deputy of Public Health, Maternal Office, Ministry of Health and Medical Education, Tehran, Iran

Farnaz Amouzegar Hashemi

Radiotherapy Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

Marjan Rahnamaye Farzami

Central Reference Laboratory, Ministry of Health and Medical Education, Tehran, Iran

Reza Shahsiah

Department of Pathology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Sima Sajedinejhad

Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Mohammad Ali Mohagheghi

Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

Fatemeh Nadali

Faculty of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran

Arash Rashidian

Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Elisabete Weiderpass

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Ole Mogensen

Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark

Kazem Zendehdel

Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Nathalie B, O’Neal Eckert L, Andreas U, Paul B. Comprehensive ...
  • Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus ...
  • Campbell CMP, Menezes LJ, Paskett ED, Giuliano AR. Prevention of ...
  • Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, MacKinnon J, ...
  • Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F. ...
  • Zwaveling S, Mota SCF, Nouta J, et al. Established human ...
  • Dikshit R, Gupta PC, Ramasundarahettige C, et al. Cancer mortality ...
  • Wasti S, Ahmed W, Jafri A, Khan B, Sohail R, ...
  • Badar F, Anwar N, Meerza F, Sultan F. Cervical carcinoma ...
  • GLOBOCAN ۲۰۱۲. Estimated Cancer Incidence, mortality and prevalence worldwide in ...
  • Khorasanizadeh F, Hassanloo J, Khaksar N, et al. Epidemiology of ...
  • Bhurgri Y, Nazir K, Shaheen Y, et al. Patho-epidemiology of ...
  • Wong YL, Chinna K, Mariapun J, Shuib R. Correlates between ...
  • De Alba I, Hubbell FA, McMullin JM, Sweningson JM, Saitz ...
  • Sengul D, Altinay S, Oksuz H, Demirturk H, Korkmazer E. ...
  • Behnamfar F, Azadehrah M. Factors associated with delayed diagnosis of ...
  • Mitton C, Donaldson C. Health care priority setting: principles, practice ...
  • World Health Organization (WHO). Priority Setting Methodologies in Health Research:A ...
  • Bryant J, Sanson-Fisher R, Walsh J, Stewart J. Health research ...
  • Forman D, Bray F, Brewster D, et al. Cancer Incidence ...
  • Viergever RF, Olifson S, Ghaffar A, Terry RF. A checklist ...
  • Al Eyd GJ, Shaik RB. Rate of opportunistic pap smear ...
  • Sancho-Garnier H, Khazraji YC, Cherif MH, et al. Overview of ...
  • Nahvijou A, Hadji M, BaratiMarnani A, et al. A systematic ...
  • Khodakarami N, Farzaneh F, Yavari P, Khayamzadeh M, Taheripanah R, ...
  • Cronjé H. Cervical screening strategies in resourced and resource-constrained countries. ...
  • Nahvijou A, Sari AA, Zendehdel K, Marnani AB. Management of ...
  • Nwankwo K, Aniebue U, Aguwa E, Anarado A, Agunwah E. ...
  • Eaker S, Adami HO, Sparen P. Reasons women do not ...
  • Jalalvandi M, Khodadoostan M. Married women and pap smear, what ...
  • Farzaneh F, Shirvani HE, Barouti E, Salehpour S, Khodakarami N, ...
  • Abedian Z, Dormahammadi M. Investigating awareness, attitude and practice of ...
  • Javanmanesh F, Dadkhah F, Zarepour N. Knowledge and awareness among ...
  • Zendehdel K, Sedigh Z, Hassanloo J, Nahvijou A. Audit of ...
  • Etemadi A, Sadjadi A, Semnani S, Nouraie SM, Khademi H, ...
  • Zendehdel K. Completeness and underestimation of cancer mortality rate in ...
  • Arbyn M, Anttila A, Jordan J, et al. European Guidelines ...
  • Andrae B, Kemetli L, Sparen P, et al. Screening-preventable cervical ...
  • Azerkan F, Sparen P, Sandin S, Tillgren P, Faxelid E, ...
  • Cutts FT, Franceschi S, Goldie S, et al. Human papillomavirus ...
  • Stanley M. Human papillomavirus vaccines versus cervical cancer screening. Clin ...
  • Khatibi M, Rasekh HR, Shahverdi Z. Cost-effectiveness evaluation of quadrivalent ...
  • Chalmers I, Bracken MB, Djulbegovic B, et al. How to ...
  • Neema S. Community participation in essential national health research process: ...
  • Mbewu A, Mngomezulu K. Health Research in South Africa. The ...
  • نمایش کامل مراجع